Iron sucrose
| Clinical data | |
|---|---|
| Trade names | Venofer |
| AHFS/Drugs.com | FDA Professional Drug Information |
| Routes of administration | Intravenous |
| ATC code | |
| Legal status | |
| Legal status |
|
| Chemical and physical data | |
| Formula | [Na2Fe5O8(OH) •3(H2O)]n •m(C12H22O11) |
| Molar mass | 34,000 to 60,000 g/mol |
Iron sucrose (brand name Venofer) is an intravenously administered iron product indicated in the treatment of iron deficiency anemia.[1] It is frequently used in patients undergoing hemodialysis, those undergoing erythropoietin therapy, and/or patients who have chronic kidney disease. It is a type 2 complex which limits the maximum dose that can be given to 1000mg which requires 5-10 administrations.
References
- ^ "Iron Sucrose (Intravenous Route)". Mayo Clinic. Retrieved 22 January 2016.
External links
- Venofer venofer on Drugs.com
- Venofer brand website
 | This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it. |